Pooled Safety Analysis of Enobosarm from Phase 2 and Phase 3 Placebo-Controlled Clinical Trials

被引：0
|
作者：
Crawford, Jeffrey
Dobs, Adrian S.
Evans, William J.
Prado, Carla
Rodriguez, Domingo
Shalev, Itay
Barnette, K. Gary
Steiner, Mitchell
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-2067-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2067-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] POOLED SAFETY AND ADVERSE EVENTS IN NINE RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 AND 3 CLINICAL TRIALS OF ALIROCUMAB
    Jones, Peter H.
    Bays, Harold
    Chaudhari, Umesh
    Pordy, Robert
    Lorenzato, Christelle
    Miller, Kathryn
    Robinson, Jennifer
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1363 - A1363
  • [2] Safety of Oral Ospemifene in Phase 2/3 Placebo-controlled Clinical Trials
    Goldstein, Steven R.
    Archer, David F.
    Graham, Shelli
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (12): : 1322 - 1322
  • [3] Overview of fremanezumab pooled safety data from placebo-controlled phase 2 and 3 studies
    Silberstein, Stephen D.
    Faulhaber, Nicola
    Ning, Xiaoping
    Yeung, Paul P.
    Schiemann, Jimmy
    Yang, Ronghua
    Ma, Yuju
    Aycardi, Ernesto
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [4] Overview of Fremanezumab Pooled Safety Data from Placebo-Controlled Phase 2 and 3 Studies
    Silberstein, S. D.
    Faulhaber, N.
    Ning, X.
    Yeung, P. P.
    Schiemann, J.
    Yang, R.
    Ma, Y.
    Aycardi, E.
    HEADACHE, 2018, 58 : 174 - 174
  • [5] Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials
    Annaswamy Raji
    Jianmin Long
    Raymond L. H. Lam
    Edward A. O’Neill
    Samuel S. Engel
    Diabetes Therapy, 2018, 9 : 1581 - 1589
  • [6] Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials
    Raji, Annaswamy
    Long, Jianmin
    Lam, Raymond L. H.
    O'Neill, Edward A.
    Engel, Samuel S.
    DIABETES THERAPY, 2018, 9 (04) : 1581 - 1589
  • [7] Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials
    Simon, James A.
    Altomare, Corrado
    Cort, Susannah
    Jiang, Wei
    Pinkerton, JoAnn V.
    JOURNAL OF WOMENS HEALTH, 2018, 27 (01) : 14 - 23
  • [8] POOLED EFFICACY AND SAFETY FROM PHASE 3 PLACEBO-CONTROLLED STUDIES OF TANEZUMAB IN PATIENTS WITH OSTEOARTHRITIS
    Tive, L.
    Radin, D.
    Bello, A.
    Brown, M.
    West, C.
    Verburg, K.
    OSTEOARTHRITIS AND CARTILAGE, 2015, 23 : A355 - A355
  • [9] Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials
    Davidson, Jaime A.
    Lajara, Rosemarie
    Aguilar, Richard B.
    Mattheus, Michaela
    Woerle, Hans-Juergen
    von Eynatten, Maximilian
    BMJ OPEN DIABETES RESEARCH & CARE, 2014, 2 (01):
  • [10] Safety of lurasidone: Pooled analysis of five placebo-controlled trials in patients with schizophrenia
    Cucchiaro, J.
    Pikalov, A.
    Ogasa, M.
    Silva, R.
    Hsu, J.
    Xu, J.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 217 - 217
12345